Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States

por Long, Millie D, Smith, Timothy W, Dibonaventura, Marco, Gruben, David, Bargo, Danielle, Salese, Leonardo, Quirk, Daniel
Publicado 2020

Review of the epidemiology and burden of ulcerative colitis in Latin America

por Kotze, Paulo Gustavo, Steinwurz, Flavio, Francisconi, Carlos, Zaltman, Cyrla, Pinheiro, Marcia, Salese, Leonardo, Ponce de Leon, Dario
Publicado 2020

Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, OCTAVE open

por Panaccione, Remo, Abreu, Maria T., Lazariciu, Irina, Mundayat, Rajiv, Lawendy, Nervin, Salese, Leonardo, Woolcott, John C., Sands, Bruce E., Chaparro, María
Publicado 2022

Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis

por Long, Millie D., Cohen, Russell D., Smith, Timothy W., DiBonaventura, Marco, Gruben, David, Bargo, Danielle, Salese, Leonardo, Quirk, Daniel
Publicado 2022

Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Cli...

por Hudesman, David P., Torres, Joana, Salese, Leonardo, Woolcott, John C., Mundayat, Rajiv, Su, Chinyu, Mosli, Mahmoud H., Allegretti, Jessica R.
Publicado 2022

The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe

por Armuzzi, Alessandro, Tarallo, Miriam, Lucas, James, Bluff, Daniel, Hoskin, Benjamin, Bargo, Danielle, Cappelleri, Joseph C., Salese, Leonardo, daCosta DiBonaventura, Marco
Publicado 2020

Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis

por Lichtenstein, Gary R., Cohen, Benjamin L., Salese, Leonardo, Modesto, Irene, Wang, Wenjin, Chan, Gary, Ahmed, Haytham Mohamed, Su, Chinyu, Peyrin-Biroulet, Laurent
Publicado 2023

Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical progr...

por Rubin, David T., Salese, Leonardo, Cohen, Mitchell, Kotze, Paulo G., Woolcott, John C., Su, Chinyu, Mundayat, Rajiv, Paulissen, Jerome, Torres, Joana, Long, Millie D.
Publicado 2023

Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies

por Dubinsky, Marla C, DiBonaventura, Marco, Fan, Haiyun, Bushmakin, Andrew G, Cappelleri, Joseph C, Maller, Eric, Thorpe, Andrew J, Salese, Leonardo, Panés, Julian
Publicado 2020

Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe

por Armuzzi, Alessandro, DiBonaventura, Marco daCosta, Tarallo, Miriam, Lucas, James, Bluff, Daniel, Hoskin, Benjamin, Bargo, Danielle, Cappelleri, Joseph C., Quirk, Daniel, Salese, Leonardo
Publicado 2020

Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib—Implications for Cardiovascular Risk and Patient Management

por Sands, Bruce E, Colombel, Jean-Frédéric, Ha, Christina, Farnier, Michel, Armuzzi, Alessandro, Quirk, Daniel, Friedman, Gary S, Kwok, Kenneth, Salese, Leonardo, Su, Chinyu, Taub, Pam R
Publicado 2020

Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical Trials

por Panés, Julian, Vermeire, Séverine, Dubinsky, Marla C, Loftus, Edward V, Lawendy, Nervin, Wang, Wenjin, Salese, Leonardo, Su, Chinyu, Modesto, Irene, Guo, Xiang, Colombel, Jean-Frederic
Publicado 2021

Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program

por Loftus, Edward V, Baumgart, Daniel C, Gecse, Krisztina, Kinnucan, Jami A, Connelly, Susan B, Salese, Leonardo, Su, Chinyu, Kwok, Kenneth K, Woolcott, John C, Armuzzi, Alessandro
Publicado 2022

Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

por Chiorean, Michael V., Allegretti, Jessica R., Sharma, Puza P., Chastek, Benjamin, Salese, Leonardo, Bell, Elizabeth J., Peterson-Brandt, Jesse, Cappelleri, Joseph C., Guo, Xiang, Khan, Nabeel
Publicado 2022

Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

por Chiorean, Michael V., Allegretti, Jessica R., Sharma, Puza P., Chastek, Benjamin, Salese, Leonardo, Bell, Elizabeth J., Peterson-Brandt, Jesse, Cappelleri, Joseph C., Guo, Xiang, Khan, Nabeel
Publicado 2022

Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program

por Lichtenstein, Gary R, Bressler, Brian, Francisconi, Carlos, Vermeire, Severine, Lawendy, Nervin, Salese, Leonardo, Sawyerr, Gosford, Shi, Hongjiong, Su, Chinyu, Judd, Donna T, Jones, Thomas, Loftus, Edward V
Publicado 2022

Improvements in Disease Activity Partially Mediate the Effect of Tofacitinib Treatment on Generic and Disease-Specific Health-Related Quality of Life in Patients with Ulcerative Co...

por Dubinsky, Marla C., Armuzzi, Alessandro, Gecse, Krisztina B., Ullman, Thomas, Bushmakin, Andrew G., DiBonaventura, Marco, Cappelleri, Joseph C., Connelly, Susan B., Woolcott, John C., Salese, Leonardo
Publicado 2023

Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials

por Feagan, Brian G., Khanna, Reena, Sandborn, William J., Vermeire, Séverine, Reinisch, Walter, Su, Chinyu, Salese, Leonardo, Fan, Haiyun, Paulissen, Jerome, Woodworth, Deborah A., Niezychowski, Wojciech, Sands, Bruce E.
Publicado 2021

Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme

por Winthrop, Kevin L, Loftus, Edward V, Baumgart, Daniel C, Reinisch, Walter, Nduaka, Chudy I, Lawendy, Nervin, Chan, Gary, Mundayat, Rajiv, Friedman, Gary S, Salese, Leonardo, Thorpe, Andrew J, Su, Chinyu
Publicado 2020

Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open

por Sands, Bruce E., Armuzzi, Alessandro, Marshall, John K., Lindsay, James O., Sandborn, William J., Danese, Silvio, Panés, Julián, Bressler, Brian, Colombel, Jean‐Frédéric, Lawendy, Nervin, Maller, Eric, Zhang, Haiying, Chan, Gary, Salese, Leonardo, Tsilkos, Konstantinos, Marren, Amy, Su, Chinyu
Publicado 2019